SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001400482-15-000055
Filing Date
2015-05-14
Accepted
2015-05-13 19:04:25
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acucela-2015033110xq.htm 10-Q 546328
2 CERTIFICATION acucela-20150331xexhibit311.htm EX-31.1 11183
3 CERTIFICATION acucela-20150331xexhibit312.htm EX-31.2 11138
4 CERTIFICATION acucela-20150331xexhibit321.htm EX-32.1 5901
5 CERTIFICATION acucela-20150331xexhibit322.htm EX-32.2 5742
  Complete submission text file 0001400482-15-000055.txt   2946476

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acuc-20150331.xml EX-101.INS 318300
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acuc-20150331.xsd EX-101.SCH 21215
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acuc-20150331_cal.xml EX-101.CAL 45673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acuc-20150331_def.xml EX-101.DEF 70908
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acuc-20150331_lab.xml EX-101.LAB 286838
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acuc-20150331_pre.xml EX-101.PRE 153714
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55133 | Film No.: 15859826
SIC: 2834 Pharmaceutical Preparations